Uzm. Dr. Işıl Erdoğan Özünal

Publication Only

HemaSphere, 2026

DOI 10.1002/hem3.70421 Açık erişimli tam metinKaynak: OpenAlex

A Key Overlooked Medical Condition: Vitamin D Deficiency in Hodgkin Lymphoma

Cerrahpaşa Medical Journal, 2026

DOI 10.5152/cjm.2026.26002 Açık erişimli tam metinKaynak: ORCID

Real-world outcomes and prognostic factors in primary mediastinal B-cell lymphoma: a multicenter study of 157 patients

Annals of Hematology, 2025

DOI 10.1007/s00277-025-06644-z PMID 41074982 2 atıf (OpenAlex) Açık erişimli tam metinKaynak: OpenAlex

High-density lipoprotein (HDL) has an impact on myeloma outcome: Lower HDL associates with worse progression-free survival

Wiener Klinische Wochenschrift, 2024

DOI 10.1007/s00508-023-02239-8 PMID 37402933 4 atıf (Europe PMC) Kaynak: ORCID

Treatment options in primary mediastinal B cell lymphoma patients, retrospective multicentric analysis; a Turkısh oncology group study

Journal of Cancer Research and Therapeutics, 2023

DOI 10.4103/jcrt.jcrt_355_22 PMID 37147993 2 atıf (OpenAlex) Açık erişimli tam metinKaynak: OpenAlex

Serum Lactate Dehydrogenase Elevates and Inversely Correlates with Platelet Count in Immune Thrombocytopenia: A Case-control Study in Adults

Hamidiye Medical Journal, 2023

DOI 10.4274/hamidiyemedj.galenos.2023.85057 1 atıf (OpenAlex) Açık erişimli tam metinKaynak: ORCID

Myeloproliferative Neoplasms and Aspirin: Does Increased Platelet Turnover Matter?

The Turkish Journal of Hematology, 2023

DOI 10.4274/tjh.galenos.2023.2022.0452 PMID 36847696 1 atıf (Europe PMC) Açık erişimli tam metinKaynak: ORCID

MM-125 Adipose Tissue Metabolic Activity in Multiple Myeloma

Clinical Lymphoma Myeloma & Leukemia, 2023

DOI 10.1016/s2152-2650(23)01406-4 Kaynak: OpenAlex

Diagnostic role of platelet indices and leukocyte count in pseudothrombocytopenia

Dokuz Eylül Üniversitesi Tıp Fakültesi Dergisi, 2022

DOI 10.18614/deutip.1174477 Açık erişimli tam metinKaynak: ORCID

Are Hematologic Patients Trojan Horse for COVID-19?

Indian Journal of Hematology and Blood Transfusion, 2022

DOI 10.1007/s12288-021-01498-7 PMID 34667375 Açık erişimli tam metinKaynak: ORCID

Investigation of 13q14.3 deletion by cytogenetic analysis and FISH technique and miRNA-15a and miRNA-16-1 by real time PCR in chronic lymphocytic leukemia

African Health Sciences, 2022

DOI 10.4314/ahs.v22i3.20 PMID 36910369 4 atıf (Europe PMC) Açık erişimli tam metinKaynak: ORCID

Prognostic Nutritional Index Predicts Early Mortality in Diffuse Large B-cell Lymphoma,Diffüz Büyük B-hücreli Lenfomada Erken Mortaliteyi Öngörmede Prognostik Nutrisyonel İndeks

Medeniyet Medical Journal, 2022

DOI 10.4274/mmj.galenos.2022.87422 PMID 35306794 5 atıf (Europe PMC) Açık erişimli tam metinKaynak: ORCID

Does high serum cobalamin level in adults require further investigation or follow-up?

Dokuz Eylül Üniversitesi Tıp Fakültesi Dergisi, 2022

DOI 10.5505/deutfd.2022.33600 Açık erişimli tam metinKaynak: OpenAlex

A rare side effect of ibrutinib: Tumor lysis syndrome,Ibrutinibin nadir bir yan etkisi: Tümör lizis sendromu

Medeniyet Medical Journal, 2021

DOI 10.5222/mmj.2021.56424 PMID 34239769 4 atıf (Europe PMC) Açık erişimli tam metinKaynak: ORCID

Investigation of 13q14.3 Deletion by Cytogenetic Analysis and FISH Technique and miRNA-15a and miRNA-16-1 by Real Time PCR in Chronic Lymphocytic Leukemia

Annals of Medical and Health Sciences Research, 2021

Kaynak: ORCID

KILLER IMMUNOGLOBULINE LIKE RECEPTOR GENE ANALYSIS IN CHRONIC LYMPHOCYTIC LEUKEMIA AND ITS RELATION WITH AUTOIMMUNITY

İstanbul Tıp Fakültesi Dergisi, 2021

DOI 10.26650/iuitfd.2020.0037 1 atıf (OpenAlex) Açık erişimli tam metinKaynak: ORCID

Genetic Features and TP53 Mutations in Chronic Lymphocytic Leukemia

Cerrahpasa Medical Journal, 2021

DOI 10.5152/cjm.2021.21021 4 atıf (OpenAlex) Açık erişimli tam metinKaynak: OpenAlex

Evaluation of Prognostic Nutritional Index and Sarcopenia in Polycythemia Vera and Essential Thrombocythemia

Cerrahpasa Medical Journal, 2021

DOI 10.5152/cjm.2021.21052 Açık erişimli tam metinKaynak: OpenAlex

Evaluation of the knowledge of intern doctors on transfusion medicine in Turkey

2020

DOI 10.21203/rs.2.22224/v1 2 atıf (OpenAlex) Açık erişimli tam metinKaynak: OpenAlex

The Outcomes of Chronic Myeloid Leukemia Patients With Molecular Warning Responses During Imatinib Treatment According to the European LeukemiaNet 2013 Recommendations

Clinical Lymphoma Myeloma and Leukemia, 2019

DOI 10.1016/j.clml.2019.03.028 PMID 31088736 4 atıf (Europe PMC) Kaynak: ORCID

Management of Major Surgical Procedures in Patients with Hemophilia: A Single-Center Experience of 49 Procedures

Blood, 2019

DOI 10.1182/blood-2019-130305 2 atıf (OpenAlex) Kaynak: OpenAlex

Ulusal, Çok Merkezli Grup Uygunsuz ‘0’ Grup Kullanımının Retrospektif Değerlendirilmesi

Bursa Uludag University - AVESIS, 2018

Kaynak: OpenAlex

HEMATOLOGLARIN HEMATOLOJİ UZMANLIK EĞİTİMİ ÇEKİRDEK MÜFREDATI TRANSFÜZYON TIBBI HEDEFİNE ULAŞIMININ DEĞERLENDİRİLMESİ

Bursa Uludag University - AVESIS, 2018

Kaynak: OpenAlex

ULUSAL, ÇOK MERKEZLİ GRUP UYGUNSUZ ’0’ GRUP KULLANIMININ RETROSPEKTİF DEĞERLENDİRİLMESİ

Bursa Uludag University - AVESIS, 2018

Kaynak: OpenAlex

TIP FAKÜLTESİ ÖĞRENCİLERİNİN ULUSAL ÇEKİRDEK EĞİTİM PROGRAMININ TRANSFÜZYON TIBBI HEDEFİNE ULAŞIMININ DEĞERLENDİRİLMESİ

Bursa Uludag University - AVESIS, 2018

Kaynak: OpenAlex

Patient personalized prophylactic factor replacement

Haemophilia, 2018

Kaynak: ORCID

Third-line treatment with second-generation tyrosine kinase inhibitors (dasatinib or nilotinib) in patients with chronic myeloid leukemia after two prior TKIs: real-life data on a single center experience along with the review of the literature

Hematology, 2018

DOI 10.1080/10245332.2017.1385193 PMID 28990873 15 atıf (Europe PMC) Açık erişimli tam metinKaynak: ORCID

Outcomes of Chronic Myeloid Leukemia Patients With Early Molecular Response at 3 and 6 Months: A Comparative Analysis of Generic Imatinib and Glivec

Clinical Lymphoma Myeloma and Leukemia, 2017

DOI 10.1016/j.clml.2017.07.255 PMID 28847475 15 atıf (Europe PMC) Kaynak: ORCID

NEUTROPHIL HYPERSEGMENTATION IN ADULTS WITH IRON DEFICIENCY: A CASE-CONTROL STUDY

Haematologica, 2017

Kaynak: ORCID

SINGLE CENTRE FX DEFICIENCY EXPERIENCE

Haematologica, 2017

Kaynak: ORCID

Real-Life Data and a Single Center Experience on the Efficacy and Toxicity Profile of Imatinib in the Treatment of Elderly Patients with Chronic Myeloid Leukemia

Blood, 2016

DOI 10.1182/blood.v128.22.1905.1905 Kaynak: OpenAlex

ACQUIRED DEFICIENCY OF VITAMIN K-DEPENDANT CLOTTING FACTORS, DESCRIPTIVE REPORT OF 3 CASES, SINGLE CENTRE EXPERIENCE

Thrombosis Research, 2016

Kaynak: ORCID

Comparison of International Prognostic Index and NCCN-IPI in 324 patients with de novo diffuse large B-cell lymphoma: A multi-center retrospective analysis

Leukemia and Lymphoma, 2016

DOI 10.3109/10428194.2015.1079319 PMID 26294270 6 atıf (Europe PMC) Kaynak: ORCID

HYPOFIBRINOGENEMIA; DESCRIPTIVE REPORT OF 5 CASES, SINGLE CENTRE EXPERIENCE

Thrombosis Research, 2016

Kaynak: ORCID

Haemophilic Arthropathy May be a Risk Factor for Decreased Bone Mineral Density and Low Vitamin D Levels

Haemophilia, 2016

Kaynak: ORCID

RETROSPECTIVE EVALUATION OF PATIENTS WITH FACTOR XI DEFICIENCY: RESULTS FROM A SINGLE CENTRE

Thrombosis Research, 2016

Kaynak: ORCID

Posttransplant Secondary Neoplasms: A Single Center Experience

Blood, 2015

DOI 10.1182/blood.v126.23.5485.5485 Kaynak: OpenAlex

Haemophilic Arthropathy Is a Risk Factor for Reduced Bone Mineral Density and Vitamin D Deficiency

Blood, 2015

DOI 10.1182/blood.v126.23.4685.4685 Kaynak: OpenAlex

BORID REGIMEN IN PATIENTS WITH MANTLE CELL LYMPHOMA

Haematologica, 2015

Kaynak: ORCID

GENERIC IMATINIB IN NEWLY DIAGNOSED CHRONIC MYELOID LEUKEMIA (CML) PATIENTS IN CHRONIC PHASE: UPDATED DATA FROM A TURKISH CML COHORT

Haematologica, 2015

Kaynak: ORCID

IMPACT OF INITIAL CHEMOTHERAPY RESPONSE AND PRETRANSPLANT DISEASE STATUS BEFORE AUTOLOGOUS TRANSPLANTATION ON SURVIVAL IN PATIENTS WITH MULTIPLE MYELOMA

Haematologica, 2015

Kaynak: ORCID

OUTCOMES OF CHRONIC PHASE CHRONIC MYELOID LEUKEMIA PATIENTS WITH 10%≤AND>10% BCR-ABL1 (IS) TRANSCRIPT LEVELS AFTER 3 MONTHS OF GENERIC IMATINIB TREATMENT

Haematologica, 2015

Kaynak: ORCID

RETROSPECTIVE EVALUATION OF 83 PATIENTS WITH HAIRY CELL LEUKEMIA TREATED WITH 3 DIFFERENT TREATMENT MODALITIES IN THE LAST TWO DECADES: A SINGLE CENTER EXPERIENCE

Haematologica, 2015

Kaynak: ORCID

Relapse after allogeneic hematopoietic stem cell transplant in patients with chronic myeloid leukemia: Tyrosine kinase inhibitors, donor lymphocyte infusions or both?

Leukemia and Lymphoma, 2015

DOI 10.3109/10428194.2015.1026819 PMID 25747967 2 atıf (Europe PMC) Kaynak: ORCID

THE EFFICACY AND SAFETY OF GENERIC IMATINIB IN PATIENTS WITH CHRONIC MYELOID LEUKEMIA (CML) AFTER SWITCHING FROM GLIVEC: UPDATED DATA FROM CERRAHPASA CML COHORT

Haematologica, 2015

Kaynak: ORCID

THIRD-LINE TREATMENT WITH 2ND GENERATION TYROSINE KINASE INHIBITORS (TKIS) IN PATIENTS WITH CHRONIC MYELOID LEUKEMIA WHO FAILED TWO PRIOR TKIS: A SINGLE CENTER EXPERIENCE OF 21 PATIENTS

Haematologica, 2015

Kaynak: ORCID

Management of Inflammatory State in Hypercholesterolemic Patients With Atorvastatin Treatment

2011

Kaynak: OpenAlex

Antiinflammatory Consequences of Atorvastatin and Glitazone Therapies on Hypercholesterolemic Rats

2011

Kaynak: OpenAlex

The Effects of Metformin and Insulin on Management of Inflammatory State of Diabetic Patients

2011

Kaynak: OpenAlex

Proinflammatory HDL levels of smokers

2008

Kaynak: OpenAlex